StuartDonaldCookMD

Neurology • Newark, NJ

Professor of Neurology, UMDNJ - New Jersey Medical School Newark

Join to view full profile

Dr. Cook is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Cook's full profile

Already have an account?

Office
90 Bergen St
Doc 8100
Newark, NJ 07103
Phone+1 973-972-2550

Fax+1 973-972-2559
Is this information wrong?

Education & Training

Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1965 - 1968
SUNY Upstate Medical UniversityInternship, Transitional Year, 1962 - 1963
University of Vermont College of MedicineClass of 1962

Certifications & Licensure

NJ State Medical License 1971 - 2021
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
Top Doctors: New York Metro Area Castle Connolly, 2003-2014
America's Top Doctors Castle Connolly, 2002-2014
NJ.com Top Doctors Castle Connolly, 2009
New York Magazine: Top Doctors Castle Connolly, 2002-2007
New Jersey Life: Top Doctors Castle Connolly, 2005
New Jersey Monthly: Top Doctors Castle Connolly, 2001, 2003
Top MD Consumers Checkbook
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI Start of enrollment: 2003 Jan 01
Completed
Phase 4
Magnetic Resonance Imaging Study of JM-4 in Multiple Sclerosis/Clinically Patients Start of enrollment: 2019 Jun 15
Not yet recruiting
Early Phase 1

Publications & Presentations

PubMed

Letter to the editor.
Stuart D Cook> ;Multiple Sclerosis and Related Disorders. 2022 Jan 1
3 citations
Increased frequency of canine distemper virus-specific antibodies in multiple sclerosis.
Christine Rohowsky-Kochan, Amy L. Davidow, P. Dowling, Stuart D. Cook> ;Brain and Behavior. 2021 Jan 1
31 citations
Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis.
Thomas Leist, Stuart D. Cook, G. Comi, Xavier Montalban, Gavin Giovannoni, Axel Nolting, Doris Damian, Sana Syed, Andrew Galazka> ;Multiple Sclerosis and Related Disorders. 2020 Oct 8
7 citations
Gray Matter Nucleus Hyperintensity After Monthly Triple-Dose Gadopentetate Dimeglumine With Long-term Magnetic Resonance Imaging.
John J. Debevits, Reshma Munbodh, Rong Wu, Paul A. Dicamillo, Chaoran Hu, Lihong Wang, Robert T. Naismith, David Karimeddini, Suhayl Dhib-Jalbut, Sviatoslav Redko, Stu...> ;Investigative Radiology. 2020 Oct 1
7 citations
Prolonged Beneficial Effect of Brief Erythropoietin Peptide JM4 Therapy on Chronic Relapsing EAE
Deeya Gaindh, Yun-Beom Choi, Michelle Marchese, Peter C. Dowling, Stuart D. Cook, Benjamin M. Blumberg, James H. Park, Wei Lu> ;Neurotherapeutics. 2021 Jan 1
16 citations
Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety.
Gavin Giovannoni, Andrew Galazka, Regina Schick, Thomas Leist, Giancarlo Comi, Xavier Montalban, Doris Damian, Fernando Dangond, Stuart D. Cook> ;Drug Safety. 2020 Jul 1
39 citations
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study:
Gavin Giovannoni, Per Soelberg Sørensen, Stuart D. Cook, Kottil Rammohan, Peter Rieckmann, Giancarlo Comi, Fernando Dangond, Christine Hicking, Patrick Vermersch> ;Multiple Sclerosis. 2019 May 1
22 citations
Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b:
Douglas S. Goodin, Anthony T. Reder, Anthony Traboulsee, David Kb Li, Dawn Langdon, Gary Cutter, Stuart D. Cook, Timothy O'Donnell, Marcelo Kremenchutzky, Joel Oger, R...> ;Multiple Sclerosis. 2019 May 1
81 citations
Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis
Stuart D. Cook, Thomas Leist, Giancarlo Comi, Xavier Montalban, Gavin Giovannoni, Axel Nolting, Christine Hicking, Andrew Galazka, Elke Sylvester> ;Multiple Sclerosis and Related Disorders. 2019 Apr 1
79 citations
Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis.
Giancarlo Comi, Stuart D. Cook, Gavin Giovannoni, Peter Rieckmann, Per Soelberg Sørensen, Patrick Vermersch, Andrew Galazka, Axel Nolting, Christine Hicking, Fernando ...> ;Multiple Sclerosis and Related Disorders. 2019 Apr 1
206 citations
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study.
Gavin Giovannoni, Per Soelberg Sørensen, Stuart D. Cook, Kottil Rammohan, Peter Rieckmann, Giancarlo Comi, Fernando Dangond, Abidemi Adeniji, Patrick Vermersch> ;Multiple Sclerosis. 2018 Oct 1
41 citations
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis: the CLARITY Extension study.
Giancarlo Comi, Stuart D. Cook, Kottil Rammohan, Per Soelberg Sørensen, Patrick Vermersch, Abidemi Adeniji, Fernando Dangond, Gavin Giovannoni> ;Therapeutic Advances in Neurological Disorders. 2018 Jan 23
14 citations
MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis.
Josefina Maranzano, David A. Rudko, Kunio Nakamura, Stuart D. Cook, Diego Cadavid, Leo J. Wolansky, Douglas L. Arnold, Sridar Narayanan> ;Neurology. 2017 Aug 15
13 citations
MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b.
Robert A. Brown, Sridar Narayanan, Nikola Stikov, Stuart D. Cook, Diego Cadavid, Leo J. Wolansky, Douglas L. Arnold> ;Neurology. 2016 Aug 30
31 citations
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
Sven Schippling, Paul O'Connor, Volker Knappertz, Christoph Pohl, Timon Bogumil, Gustavo Suarez, Stuart D. Cook, Massimo Filippi, Hans-Peter Hartung, Giancarlo Comi, D...> ;Journal of Neurology. 2016 May 13
109 citations
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b
Kathryn C. Fitzgerald, Kassandra L. Munger, Karl Köchert, Giancarlo Comi, Stuart D. Cook, Douglas S. Goodin, Massimo Filippi, Hans-Peter Hartung, Douglas Jeffery, Paul...> ;JAMA Neurology. 2015 Dec 1
13 citations
Long-Term Outcomes of High-Risk Keratoplasty in Patients Receiving Systemic Immunosuppression.
Sing-Pey Chow, Stuart D Cook, Derek M Tole> ;Cornea. 2015 Nov 1
3 citations
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b
Hans-Peter Hartung, Ludwig Kappos, Douglas S. Goodin, Paul O'Connor, Massimo Filippi, Barry G. W. Arnason, Giancarlo Comi, Stuart D. Cook, Douglas Jeffery, John Petkau...> ;Journal of Neurology. 2015 Aug 5
4 citations
Hypophosphatemia is Associated with the Serial Administration of Triple-Dose Gadolinium to Patients for Brain MRI.
Leo J. Wolansky, Diego Cadavid, Vineet Punia, Soyeon Kim, Jojy Cheriyan, Mershad Haghighi, Stuart D. Cook> ;Journal of Neuroimaging. 2015 May 1
14 citations
Fatal acute liver failure with hepatitis B virus infection during nataluzimab treatment in multiple sclerosis.
Machteld Hillen, Stuart D. Cook, Arun Samanta, Evan Grant, James R. Quinless, Jamuna K. Rajasingham> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2015 Apr 1
31 citations
Intraocular lens opacification after descemet stripping automated endothelial keratoplasty.
Muhammad A. Ahad, Kieren Darcy, Stuart D Cook, Derek M Tole> ;Cornea. 2014 Dec 1
9 citations
Effects of Inhibitors of the Renin-Angiotensin System on the Efficacy of Interferon beta-1b: A post hoc Analysis of the BEYOND Study
M Doerner, K. Beckmann, Volker Knappertz, Ludwig Kappos, H.-P. Hartung, Massimo Filippi, Paul O'Connor, Stuart D. Cook, Douglas Jeffery, G. Comi, Volker Limmroth, Barr...> ;European Neurology. 2014 Jan 21
33 citations
Peripheral ulcerative keratitis and corneal melt: a 10-year single center review with historical comparison.
Nathaniel E. Knox Cartwright, Derek M Tole, Panagiotis Georgoudis, Stuart D Cook> ;Cornea. 2014 Jan 1
27 citations
Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis
Hans-Peter Hartung, Lawrence Steinman, Douglas S. Goodin, Giancarlo Comi, Stuart D. Cook, Massimo Filippi, Paul O'Connor, Douglas Jeffery, Ludwig Kappos, Robert C. Axt...> ;JAMA Neurology. 2013 Aug 1
41 citations
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.
Giancarlo Comi, Stuart D. Cook, Gavin Giovannoni, Kottil Rammohan, Peter Rieckmann, Per Soelberg Sørensen, Patrick Vermersch, A Hamlett, Vissia Viglietta, Steven J. Gr...> ;Journal of Neurology. 2013 Apr 1
Join now to see all

Press Mentions

Blocking IL-11 Signaling Can Promote Liver Regeneration After Paracetamol-Induced DamageJune 18th, 2021
Cardiovascular Magnetic Resonance Predictors of Heart Failure in Hypertrophic Cardiomyopathy: The Role of Myocardial Replacement Fibrosis and the MicrocirculationMarch 8th, 2021
All in on IL-11, Frazier Unveils Latest Startup with Dual Focus on Fibrosis and CancerJune 17th, 2020
Join now to see all

StuartDonaldCookMD

Dr. Cook is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.